Additionally, parthenolide inhibits NF-κB activity via inhibiting IKβ kinase and by modifying p65 at a key cysteine residue in its activation loop [19], and has been shown to reduce Akt phosphorylation and activate mitochondrial apoptosis signaling in GBM cells [20]. The gene discussed is NFKB1; the disease is glioblastoma.